These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38394463)
1. Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection. Cotroneo N; Stokes SS; Pucci MJ; Rubio A; Hamed KA; Critchley IA J Antimicrob Chemother; 2024 Apr; 79(4):875-882. PubMed ID: 38394463 [TBL] [Abstract][Full Text] [Related]
2. The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria. Pennings LJ; Ruth MM; Wertheim HFL; van Ingen J Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468478 [TBL] [Abstract][Full Text] [Related]
3. Aragaw WW; Cotroneo N; Stokes S; Pucci M; Critchley I; Gengenbacher M; Dick T Microbiol Spectr; 2022 Feb; 10(1):e0132121. PubMed ID: 35019671 [TBL] [Abstract][Full Text] [Related]
4. Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720. Winthrop KL; Flume P; Hamed KA Expert Rev Anti Infect Ther; 2023; 21(11):1177-1187. PubMed ID: 37862563 [TBL] [Abstract][Full Text] [Related]
5. First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections. Talley AK; Thurston A; Moore G; Gupta VK; Satterfield M; Manyak E; Stokes S; Dane A; Melnick D Antimicrob Agents Chemother; 2021 Oct; 65(11):e0120821. PubMed ID: 34491803 [TBL] [Abstract][Full Text] [Related]
7. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex. Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265 [No Abstract] [Full Text] [Related]
8. Kim DH; Zo S; Kim SY; Jhun BW Ann Lab Med; 2024 Jan; 44(1):92-96. PubMed ID: 37665290 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract. He G; Wu L; Zheng Q; Jiang X Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867 [No Abstract] [Full Text] [Related]
10. Sudapyridine (WX-081) antibacterial activity against Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581 [TBL] [Abstract][Full Text] [Related]
11. Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania. Maya TG; Komba EV; Mensah GI; Mbelele PM; Mpagama SG; Mfinanga SG; Addo KK; Kazwala RR PLoS One; 2022; 17(3):e0265358. PubMed ID: 35324922 [TBL] [Abstract][Full Text] [Related]
12. Cumulative antimicrobial susceptibilities for respiratory clinical isolates of Shakoor S; Shafiq S; Shahid A; Mir F; Ali R; Hasan R Int J Mycobacteriol; 2023; 12(3):310-315. PubMed ID: 37721238 [TBL] [Abstract][Full Text] [Related]
13. Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Fröberg G; Maurer FP; Chryssanthou E; Fernström L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyryläinen HL; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schön T; Clin Microbiol Infect; 2023 Jun; 29(6):758-764. PubMed ID: 36813087 [TBL] [Abstract][Full Text] [Related]
14. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance. Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842 [TBL] [Abstract][Full Text] [Related]
15. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice. Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865 [TBL] [Abstract][Full Text] [Related]
16. Zhu R; Shang Y; Chen S; Xiao H; Ren R; Wang F; Xue Y; Li L; Li Y; Chu N; Huang H Microbiol Spectr; 2022 Dec; 10(6):e0137222. PubMed ID: 36250885 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease. Park S; Jo KW; Lee SD; Kim WS; Shim TS Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]